Intravitreal Injection
-
Daniels receives research grant from Knights Templar Eye Foundation to study retinoblastoma treatment
Vanderbilt investigator Anthony Daniels has received a grant from the Knights Templar Eye Foundation to develop new, safe and effective treatments for retinoblastoma, the most common ocular cancer in children. Read MoreJun 25, 2015
-
Common eye treatments can lead to antibiotic-resistant ‘superbugs’
A new study shows ophthalmologic antibiotics promote antimicrobial resistance, prompting a call from Vanderbilt Eye Institute physicians to be more judicial in administering the drugs. Read MoreSep 15, 2011